What is Becton, Dickinson and Company's R&D?

Becton, Dickinson and Company (BDX) reported R&D of $249M in Q1 2026.

How has Becton, Dickinson and Company's R&D changed year-over-year?

Becton, Dickinson and Company's R&D increased by 7.3% year-over-year, from $232M to $249M.

What is the long-term trend for Becton, Dickinson and Company's R&D?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's R&D has grown at a -2.2% compound annual growth rate (CAGR), from $1.31B to $1.19B.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Becton, Dickinson and Company BDX R&D

R&D at other companies

AbbottABT

$767M+7.1%

Baxter InternationalBAX

$139M-0.7%

Bio-Rad LaboratoriesBIO

$62.9M-14.4%

TFX

TeleflexTFX

$44.39M+75.5%

Thermo Fisher ScientificTMO

$336M-1.8%

West Pharmaceutical ServicesWST

$15.8M-3.1%

Segments

By segment

See full

Medical$523M+17.0%

Connected Care$90M+21.6%

Interventional$72M+14.3%

Medical Essentials$53M+10.4%

BioPharma Systems$17M-5.6%

Other financials

Income statement

See full

Revenue$4.7B+5.2%

Gross profit$2.2B+15.7%

Operating income$93.0M-75.7%

Net income-$311.0M-201%

EPS (diluted)-$1.11-204%

Balance sheet

See full

Cash & equivalents$1.0B+49.0%

Total debt$14.7B-16.8%

Total equity$24.1B-4.4%

Total assets$50.8B-6.7%

Cash flow

See full

Operating cash flow$671.0M—

CapEx$125.0M+9.6%

Free cash flow$546.0M—

Valuation

See full

Market cap$42.96B-12.6%

Enterprise value$56.65B-14.0%

P/E37.8×+6.7×

P/S2×-0.4×

Profitability

See full

Gross margin46.8%+2.5pp

Operating margin10.4%+0.1pp

Net margin5.3%-2.1pp

FCF margin16.4%—

Returns & leverage

See full

Return on equity4.6%-1.3pp

Debt / equity0.6×-0.1×

Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Becton, Dickinson and Company's R&D?: Becton, Dickinson and Company (BDX) reported R&D of $249M in Q1 2026.
How has Becton, Dickinson and Company's R&D changed year-over-year?: Becton, Dickinson and Company's R&D increased by 7.3% year-over-year, from $232M to $249M.
What is the long-term trend for Becton, Dickinson and Company's R&D?: Over 4 years (2021 to 2025), Becton, Dickinson and Company's R&D has grown at a -2.2% compound annual growth rate (CAGR), from $1.31B to $1.19B.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.